Date,Title,Source
2025-09-27T06:22:42Z,Edgewise Therapeutics (NASDAQ:EWTX) Upgraded at The Goldman Sachs Group,ETF Daily News
2025-09-27T05:22:53Z,The Goldman Sachs Group Initiates Coverage on Edgewise Therapeutics (NASDAQ:EWTX),ETF Daily News
"Thu, 25 Sep 2025 12:03:00 GMT",Goldman Sachs Initiates Coverage of Edgewise Therapeutics (EWTX) with Neutral Recommendation - Nasdaq,Nasdaq
"Thu, 25 Sep 2025 12:20:00 GMT",New Analyst Forecast: $EWTX Given $20.0 Price Target - Quiver Quantitative,Quiver Quantitative
"Thu, 25 Sep 2025 19:31:16 GMT",Edgewise Therapeutics (NASDAQ:EWTX) Trading Down 8.5% - Here's Why - MarketBeat,MarketBeat
"Wed, 24 Sep 2025 21:31:00 GMT","Goldman Sachs Initiates Edgewise Therapeutics(EWTX.US) With Hold Rating, Announces Target Price $20 - 富途牛牛",富途牛牛
"Fri, 26 Sep 2025 11:11:22 GMT","Edgewise Therapeutics (NASDAQ:EWTX) Raised to ""Hold"" at The Goldman Sachs Group - MarketBeat",MarketBeat
"Thu, 25 Sep 2025 12:17:32 GMT",The Goldman Sachs Group Begins Coverage on Edgewise Therapeutics (NASDAQ:EWTX) - MarketBeat,MarketBeat
"Wed, 24 Sep 2025 17:17:50 GMT",Edgewise Therapeutics (NASDAQ:EWTX) Trading 8.5% Higher - Should You Buy? - MarketBeat,MarketBeat
"Sat, 27 Sep 2025 06:25:11 GMT",Edgewise Therapeutics (NASDAQ:EWTX) Upgraded at The Goldman Sachs Group - Defense World,Defense World
